EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
About this episode
Dr Suresh S Ramalingam and Dr Helena Yu discuss therapy selection for EGFR mutation-positive non-small cell lung cancer and recent treatment advances.
Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year. CME information and select publications here .
People in this episode
Host: Dr Neil Love
Guests: Dr Suresh S Ramalingam, Dr Helena Yu
Topics covered
- EGFR mutation
- non-small cell lung cancer
- therapy selection
- treatment advances
- oncology
Keywords
- EGFR mutation
- non-small cell lung cancer
- therapy sequencing
- treatment landscape
- oncology advances
Mentioned in this episode
Organizations: EGFR, non-small cell lung cancer
More episodes of Lung Cancer Update
- Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
- Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
- Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
- HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
- Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Explore listener stats, chart rankings, contacts and more on the Lung Cancer Update podcast page.